Concurrent chemotherapy and radiation therapy for advanced stage carcinoma of the nasopharynx

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 5, 2000, Pages 1277-1279

  Cooper, Jay S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ACUTE TOXICITY; ADVANCED CANCER; ANEMIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; HUMAN; LEUKOPENIA; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; HUMANS; NASOPHARYNGEAL NEOPLASMS; RADIATION-SENSITIZING AGENTS; SURVIVAL RATE;

EID: 0034564178     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00778-1     Document Type: Editorial

References (4)

1. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma. A Radiation Therapy Oncology Group study
2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. Phase III randomized Intergroup study 0099
3. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
4. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx; Preliminary corroboration of the Intergroup experience